跳至主要内容
临床试验/ACTRN12606000102572
ACTRN12606000102572招募中4 期

europsychiatric, Neurocognitive And Quality Of Life Outcomes In Patients With Epilepsy Treated With Levetiracetam (Keppra) Verses Older AEDs As First Substitution Monotherapy.

Associate Prof. Terence O'Brien and RMH Neurosciences Foundation0 个研究点目标入组 200 人开始时间: 2006年3月16日最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
16 Years 至 90 Years(—)
性别
All

入选标准

  • Patients with Epilepsy (except for primary generalised epilepsy), who have failed treatment with their first anti epileptic drug.

排除标准

  • Patients with Primary generalised epilepsy, and patients with major psychiatric morbidity, substance abuse, intellectual disability (inability to consent), and those women plannning pregnancy.

研究者

发起方
Associate Prof. Terence O'Brien and RMH Neurosciences Foundation

相似试验